Information  X 
Enter a valid email address

Puretech Health PLC Ord 1P (PRTC)

Date Time Source Announcement
25 May 2022 7:00 am
RNS
Transaction in Own Shares
24 May 2022 8:05 am
RNS
PRTC's Vedanta Presents Data at DDW Annual Meeting
  7:00 am
RNS
Transaction in Own Shares
23 May 2022 7:00 am
RNS
Transaction in Own Shares
20 May 2022 7:00 am
RNS
Transaction in Own Shares
19 May 2022 7:00 am
RNS
PDMR Notification RSU Vesting
  7:00 am
RNS
Transaction in Own Shares
18 May 2022 7:00 am
RNS
Transaction in Own Shares
17 May 2022 12:00 pm
RNS
PRTC to Present at UBS Healthcare Conference
  7:00 am
RNS
Transaction in Own Shares
16 May 2022 2:30 pm
RNS
PRTC Presents LYT-100 Data at ATS Conference
  7:00 am
RNS
Transaction in Own Shares
13 May 2022 7:00 am
RNS
Transaction in Own Shares
12 May 2022 7:00 am
RNS
Transaction in Own Shares
11 May 2022 7:00 am
RNS
Transaction in Own Shares
10 May 2022 7:00 am
RNS
Transaction in Own Shares
09 May 2022 7:00 am
RNS
PRTC Share Buyback Programme Commences Purchases
05 May 2022 7:00 am
RNS
PRTC Announces Share Buyback Programme Up to $50M
04 May 2022 11:35 am
RNS
Gelesis Presents GS200 Weight Loss Data at ECO
03 May 2022 7:00 am
RNS
Total Voting Rights
29 Apr 2022 11:05 am
RNS
Gelesis Data: Therapeutic Shows Gut Health Benefit
26 Apr 2022 7:00 am
RNS
PRTC Final Results & Publication of Annual Report
13 Apr 2022 4:44 pm
RNS
PRTC's Vedanta Publishes VE303 Data
12 Apr 2022 12:05 pm
RNS
Akili Depression Data Published in AJP
  7:00 am
RNS
Glyph: 20x Oral Bioavailability of Buprenorphine
07 Apr 2022 7:00 am
RNS
Notice of Results
01 Apr 2022 7:00 am
RNS
Total Voting Rights
24 Mar 2022 7:00 am
RNS
PRTC Appoints Merck Vet to BOD & Audit Committee
17 Mar 2022 1:05 pm
RNS
Akili Adds Gaming Vet as Chief Product Officer
16 Mar 2022 10:35 am
RNS
Gelesis: Record-Breaking Plenity Prescriptions
08 Mar 2022 12:05 pm
RNS
Akili Named to World's Most Innovative Companies
18 Feb 2022 4:30 pm
RNS
Holding(s) in Company
17 Feb 2022 12:05 pm
RNS
Akili Data: Enhanced Brain Activity in Kids w/ADHD
15 Feb 2022 7:00 am
RNS
PRTC's Akili Files Registration Statement on S-4
10 Feb 2022 12:00 pm
RNS
PRTC to Present at Leerink Healthcare Conference
04 Feb 2022 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
31 Jan 2022 11:50 am
RNS
PRTC's Gelesis Launches Plenity Media Campaign
26 Jan 2022 12:02 pm
RNS
PRTC's Akili to Become Public & $162M Funding
14 Jan 2022 7:00 am
RNS
PRTC's Gelesis to Debut on NYSE Today Ticker GLS
07 Jan 2022 12:00 pm
RNS
PureTech to Present at JPM Healthcare Conference
06 Jan 2022 7:00 am
RNS
LYT-100 Shows Improved AE Profile vs Pirfenidone
05 Jan 2022 12:05 pm
RNS
Gelesis Adds to BOD & Declared Effective by SEC
20 Dec 2021 7:00 am
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Dec 2021 7:00 am
RNS
PRTC Provides Recap Ahead of Catalyst-Rich 2022
08 Dec 2021 12:00 pm
RNS
PRTC Presents Data at ACNP Conference For LYT-300
07 Dec 2021 12:00 pm
RNS
PRTC's Lymphatic Platform Candidate Human Study
01 Dec 2021 12:10 pm
RNS
PRTC: Gelesis' Plenity Now Broadly Available in US
  7:00 am
RNS
Total Voting Rights
18 Nov 2021 12:10 pm
RNS
PRTC's Gelesis Receives $30M Plenity Order from Ro
16 Nov 2021 12:00 pm
RNS
PRTC Publishes Previous LYT-100 MAD Study Results
15 Nov 2021 12:00 pm
RNS
PRTC Presents at Two Upcoming Investor Conferences
12 Nov 2021 12:00 pm
RNS
PRTC Presents Immunooncology Ph 1/2 Trial at SITC
11 Nov 2021 12:00 pm
RNS
FDA Grants PRTC's LYT-200 Orphan Drug Designation
10 Nov 2021 7:00 am
RNS
PRTC Receives $100M from Founded Entity Shares
09 Nov 2021 12:34 pm
RNS
KRTX and Zai Lab to Develop KarXT in Greater China
  7:00 am
RNS
PRTC Presents at Jefferies Healthcare Conference
01 Nov 2021 10:20 am
RNS
New Research in Journal Nature on Gelesis Tech
  7:00 am
RNS
Total Voting Rights
22 Oct 2021 6:00 pm
RNS
Holdings in Company - TR-1 Correction Announcement
20 Oct 2021 4:35 pm
RNS
Price Monitoring Extension

a d v e r t i s e m e n t